REPAGLINIDE | A207209 | MACLEODS PHARMACEUTICALS LTD
Highest NADAC/Unit
$0.0917
per ea
Lowest NADAC/Unit
$0.0761
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 72603081201REPAGLINIDE 2 MG TABLET | $0.0917 | EA | Generic | — | 2026-06-17 |
| 33342025011REPAGLINIDE 2 MG TABLET | $0.0917 | EA | Generic | — | 2026-06-17 |
| 72603081101REPAGLINIDE 1 MG TABLET | $0.0887 | EA | Generic | — | 2026-06-17 |
| 33342024911REPAGLINIDE 1 MG TABLET | $0.0887 | EA | Generic | — | 2026-06-17 |
| 72603081001REPAGLINIDE 0.5 MG TABLET | $0.0761 | EA | Generic | — | 2026-06-17 |
| 33342024811REPAGLINIDE 0.5 MG TABLET | $0.0761 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.